Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
30/07/2026 21:06
BRIEF-Fulgent Genetics Q2 Revenue USD 85.389 Million Jul 30 (Reuters) - Fulgent Genetics Q2 operating expenses USD 61.752 million.
- Q2 operating income USD -36.073 million
- Q2 gross profit USD 25.679 million
- Q2 pretax profit USD -29.69 million
- Q2 adjusted EBITDA USD -17.1 million
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview